Resistant Starch for Chronic Kidney Disease (ReSPECKD Trial)

"Per the information reported on clinicaltrials.gov, this trial is actively sourcing participants. Initially posted in September 2022, it was last updated at the same time."

"Affirmative. As per the data on clinicaltrials.gov, this trial is actively recruiting participants since September 27th 2022 - when it was initially listed - and has been updated as of that same date. 36 patients are required from 1 medical centre for enrollment into the study."

"During the experimental period (between weeks 12 and 26), this medical trial will measure changes in blood uremic toxin levels, Edmonton Symptom Assessment Scale scores, identified Operational Taxonomic Units of gut microbiome populations, and Medical Outcomes Study Short Form 36-item questionnaire results. These latter two assessments are used to monitor participant health status with higher values indicating better well-being."

"This research is seeking 36 individuals with chronic kidney disease (CKD) between 18 and 85 years old. To participate, candidates must have had an estimated glomerular filtration rate (eGFR) of less than 15 mL/min/1.73m^2 for the past 3 months and be able to comply with all trial requirements as determined by their doctor."

"This clinical experiment's eligibility criteria necessitates that participants are between 18 and 85 years old. There are also 43 studies for minors, as well as 458 for senior citizens."